The Potential of Oxytocin to Reduce Opioid Abuse Liability and Pain Among Older Adults

NCT05761860 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Pain

Interventions

DRUG: OxyCODONE 5 mg Oral Tablet
DRUG: OxyCODONE 2.5 mg Oral Tablet
OTHER: Placebo oxyCODONE Oral Tablet
DRUG: Oxytocin Nasal Spray (48 IU)
OTHER: Placebo Oxytocin Nasal Spray

Sponsor

University of Florida

Collaborators

[object Object]